FOR IN VITRO AND PRE-CLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE
Metabolic

MOTS-c 10mg

10mg mitochondrial research peptide

From€39.00
In Stock · Ships within 48h
Reviews coming soonBe among the first to share your research experience.
Download Certificate of Analysis
  • EU Dispatch
  • CoA Included — Every Batch
  • Discreet Packaging
Purity≥98% HPLC
FormLyophilised Powder
Storage2–8°C
OriginEuropean Stock
DispatchWithin 48h
SKUUL-MOT-10MG
≥98% PureHPLC verified
HPLC TestedDual identity check
EU DispatchShips within 48h
CoA Incl.Every batch
Research Profile

Why MOTS-c Fascinates Researchers

MOTS-c — Mitochondrial Open Reading Frame of the 12S rRNA type-c — is a sixteen-amino-acid peptide encoded not within the nuclear genome, as was long assumed for all bioactive peptides, but within the mitochondrial genome itself. Its discovery in 2015 by Changhan David Lee and colleagues fundamentally challenged the canonical view of mitochondrial DNA as a passive archive encoding only respiratory chain components.

Mitochondrial Origin & Metabolic Regulation

The mitochondrial genome encodes only thirteen protein-coding genes — all components of the oxidative phosphorylation machinery — along with ribosomal RNAs and transfer RNAs. Within the 12S ribosomal RNA gene, Lee's group identified a conserved open reading frame encoding MOTS-c. The finding that a small, secreted peptide with hormone-like systemic effects could originate from the mitochondrial genome opened an entirely new class of signalling molecules: mitochondrial-derived peptides (MDPs), of which MOTS-c is the most extensively characterised member.

The foundational 2015 Cell Metabolism paper by Lee and colleagues demonstrated that MOTS-c administration in high-fat-diet-fed mice improved insulin sensitivity, reduced fat accumulation, and enhanced glucose tolerance — effects mediated largely through activation of the AMPK pathway and downstream effects on the folate cycle and de novo purine synthesis. A striking feature of the paper was the demonstration that MOTS-c translocates from mitochondria to the nucleus in response to metabolic stress, where it appears to regulate AMPK-target gene expression directly.

Exercise Biology & Physical Performance

A 2021 Nature Communications paper by Reynolds and colleagues demonstrated that MOTS-c levels in blood increase in response to physical exercise in both mice and humans, and that MOTS-c administration in aged mice improved physical performance markers including grip strength, endurance capacity, and lean body mass — phenotypes consistent with attenuation of age-associated muscle decline. The authors proposed that MOTS-c functions as an exercise-induced mitokine, communicating mitochondrial metabolic status to peripheral tissues to coordinate systemic adaptation.

Ageing Biology

Circulating MOTS-c levels in humans decline with age, parallel to the broader pattern of mitochondrial dysfunction in ageing tissues. Genetic association studies have identified MOTS-c sequence variants enriched in centenarian populations in multiple ethnic cohorts, suggesting a potential role for MOTS-c signalling in human longevity biology. The precise mechanisms by which MOTS-c intersects with established ageing pathways — including mTOR, FOXO, and mitochondrial quality control — remain active areas of investigation.

This content is for informational purposes only and reflects the state of preclinical research. It does not constitute medical advice, endorsement of human use, or therapeutic claims of any kind.

Manufacturing Standards

Our Quality Commitment

HPLC Verified

Purity confirmed by High-Performance Liquid Chromatography at an accredited EU laboratory.

≥98% Purity

Every batch meets or exceeds 98% purity. CoA available for verification before dispatch.

Batch Traceability

Each vial is traceable to its synthesis batch, testing date, and analytical records.

Cold Chain Storage

European stock stored at optimal temperature from synthesis to dispatch.

48h EU Dispatch

Orders ship from EU stock within 48 hours with discrete, temperature-appropriate packaging.

CoA Included

Certificate of Analysis issued for every batch, available for download on request.

Download CoA for MOTS-c 10mg
Peer-Reviewed Literature

Key Scientific Studies

Peer-reviewed research supporting MOTS-c investigation.

[01]
Lee C, Zeng J, Drew BG, et al. (2015) — Cell Metabolism

“The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance”

Discovery paper establishing MOTS-c as a functional mitochondrial-encoded peptide with systemic metabolic effects. Administration to high-fat-diet mice improved insulin sensitivity, reduced adiposity, and enhanced glucose tolerance. Mechanistic studies identified AMPK activation and folate/purine cycle modulation as downstream mediators. Nuclear translocation of MOTS-c under metabolic stress was demonstrated for the first time.

View on PubMed
[02]
Reynolds JC, Lai RW, Woodhead JST, et al. (2021) — Nature Communications

“MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis”

Landmark study demonstrating that MOTS-c circulating levels increase during exercise in humans and mice, and that exogenous MOTS-c administration improves physical performance in aged mice — including grip strength and endurance — without observed adverse effects. The study positions MOTS-c as an exercise-induced mitokine with potential relevance to sarcopenia and musculoskeletal ageing research.

View on PubMed
[03]
Kim SJ, Xiao J, Wan J, Cohen P, Yen K. (2017) — Aging

“Mitochondrially derived peptides as novel regulators of metabolism”

A comprehensive review contextualising MOTS-c within the broader class of mitochondrial-derived peptides (MDPs) including humanin and SHLP1-6. The authors examine mechanisms of MDP secretion, receptor identification, and downstream signalling, providing a framework for understanding how mitochondrial genome-encoded signals coordinate systemic metabolic physiology.

View on PubMed
[04]
Zempo H, Kim SJ, Fuku N, et al. (2021) — Aging Cell

“A pro-diabetogenic mtDNA polymorphism in the MOTS-c coding region”

Genetic association study identifying a naturally occurring variant in the MOTS-c coding sequence (m.1382 A>C) that produces a non-synonymous amino acid change in the encoded peptide. The variant allele is associated with increased type 2 diabetes risk in Japanese cohorts, providing human genetic evidence for MOTS-c's role in metabolic regulation.

View on PubMed

All studies referenced are independent third-party research. UNIK LAB makes no claims regarding the therapeutic efficacy of any compound and does not represent or endorse the conclusions of cited studies. All referenced research was conducted under controlled laboratory or clinical conditions; results may not be predictive of effects in other experimental contexts.

Common Questions

Research FAQ

Answers to the most frequently asked questions about MOTS-c.

Same Category

Similar Compounds

Other Metabolic research compounds from our catalogue.

Your Longevity Research Guide Awaits

Subscribe to receive new compound profiles, CoA updates, and curated research digests — delivered directly to your inbox.